
Jeevan Raksha Aushadi Private Limited
About Jeevan Raksha Aushadi Private Limited
Data last updated:
Jeevan Raksha Aushadi Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52310DL2019PTC359231. Its GSTIN is 07AAECJ7232L1ZC (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Suresh Mittal (Whole-Time Director) and Brij Mohan Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 92 Plot No. 43 Bathla Apartment, Ip Extesnion, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.36 Cr, a growth of 73% compared to the previous year. For the same year it recorded a net profit of ₹6.27 Lakh (net margin 2.7%) and EBITDA of ₹11.73 Lakh (EBITDA margin 5%).
As per MCA filings, the company has open charges of ₹1.09 Cr on record.
Company details
Contact details
Jeevan Raksha Aushadi Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 92 Plot No. 43 Bathla Apartment, Ip Extesnion, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jeevan Raksha Aushadi Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jeevan Raksha Aushadi is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Jeevan Raksha Aushadi Private Limited, buy the company report.
Financials of Jeevan Raksha Aushadi Private Limited
FY 2025 filings availableJeevan Raksha Aushadi Private Limited reported revenue of ₹2.36 Cr (up 73% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 73% in the latest year. EBITDA rose 103% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jeevan Raksha Aushadi Private Limited, buy the company report.
Board of directors of Jeevan Raksha Aushadi Private Limited
Jeevan Raksha Aushadi has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Mohan Aggarwal Also directs: Valuecreate Ventures LLP, Rxassist Medicare Private Limited | Director | 24 Dec 2019 | 6 Years 10 Months | Current |
| Nevaid Aggarwal | Director | 10 Oct 2024 | 2 Years 0 Months | Current |
| Rajni Mittal | Director | 08 Aug 2024 | 2 Years 2 Months | Current |
| Suresh Mittal | Whole-Time Director | 28 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Jeevan Raksha Aushadi Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Newmet Pharmaceuticals Private Limited | ₹2.36 Cr (FY 2025) | 11.0% | Ghaziabad, Uttar Pradesh, India | |||
| Saphire Biotech Private Limited | ₹2.36 Cr (FY 2024) | 14.0% | Bhopal, Madhya Pradesh, India | |||
| Jeevan Raksha Aushadi Private Limitedthis company | ₹2.36 Cr (FY 2024) | ₹6.27 Lakh | 2.7% | 73.0% | Delhi, India | |
| Ramps Life Care Private Limited | ₹2.36 Cr (FY 2024) | 90.0% | Bahadurpur Patna, Bihar, India | |||
| Zurinovo Healthcare Private Limited | ₹2.36 Cr (FY 2025) | 14.0% | Chennai, Tamil Nadu, India | |||
| Assentus Biogenics Private Limited | ₹2.34 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Jeevan Raksha Aushadi Private Limited, buy the company report.
Auditor
Jeevan Raksha Aushadi Private Limited is audited by A P S R & COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A P S R & COMPANY | FY 2022 | 012581C |
Shareholding
The shareholding of Jeevan Raksha Aushadi Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Jeevan Raksha Aushadi Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Nov 2024 | 100999816 | Others | ₹1 Cr | Open | |
| 24 Jun 2022 | 100648946 | Hdfc Bank Limited | ₹9 Lakh | Open |
To see the full charge records of Jeevan Raksha Aushadi Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Jeevan Raksha Aushadi Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jeevan Raksha Aushadi Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jeevan Raksha Aushadi has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECJ7232L1ZC | Delhi | Active | 16 Aug 2021 |
To see the full GST registrations and return filing status of Jeevan Raksha Aushadi Private Limited, buy the company report.
Recent activity
Jeevan Raksha Aushadi Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Nevaid Aggarwal was appointed as Director on 10 Oct 2024.
Frequently asked questions
Jeevan Raksha Aushadi is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 December 2019 (7+ years old) and is registered under CIN U52310DL2019PTC359231.
Jeevan Raksha Aushadi has 4 current directors:
- Suresh Mittal - Whole-Time Director
- Brij Mohan Aggarwal - Director
- Nevaid Aggarwal - Director
- Rajni Mittal - Director
The latest financial statements of Jeevan Raksha Aushadi on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Jeevan Raksha Aushadi is 07AAECJ7232L1ZC, registered in Delhi.
The CIN (Corporate Identification Number) of Jeevan Raksha Aushadi is U52310DL2019PTC359231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jeevan Raksha Aushadi was incorporated on 24 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Jeevan Raksha Aushadi by revenue are Newmet Pharmaceuticals Private Limited, Saphire Biotech Private Limited, Ramps Life Care Private Limited, Zurinovo Healthcare Private Limited, Assentus Biogenics Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Nevaid Aggarwal was appointed as Director on 10 Oct 2024. Rajni Mittal was appointed as Director on 08 Aug 2024. Suresh Mittal ceased to be Additional Director on 30 Sep 2021. Jeevan Raksha Aushadi has 6 board changes on record in total.
The registered office of Jeevan Raksha Aushadi is at C – 92 Plot No. 43 Bathla Apartment, Ip Extesnion, Delhi, India – 110092.
Jeevan Raksha Aushadi operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Jeevan Raksha Aushadi has open charges of ₹1.09 Cr and no satisfied charges on record as per latest MCA filings.

